ICD-10-CM Billable Code

D04.7

Carcinoma in situ of skin of lower limb, including hip

Clinical Classification Guidelines

Medical Intelligence & Overview

Carcinoma in situ of the skin of the lower limb, including the hip, is a non-invasive form of skin cancer characterized by abnormal cell growth confined to the outermost skin layers. The term 'in situ' indicates that the cancer cells have not spread to deeper tissues or other parts of the body. Understanding this condition is essential for early detection and management, which can significantly improve outcomes.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from sunlight or tanning beds Chronic skin injuries or inflammation that may lead to cellular changes Fair skin that offers less protection against UV radiation History of skin cancer or precancerous skin lesions Exposure to specific chemicals or carcinogens in the environment Immunosuppressed states, such as after organ transplantation or with certain medical conditions

Key Symptoms: Appearance of a persistent, scaly, or crusted patch on the skin Lesions that may look like a redness or new skin growth that does not heal Lesions with irregular borders or color variations Possible small ulcers or sores that do not go away Sensations of itchiness, tenderness, or soreness in the affected area Generally, the lesion remains localized without symptoms of pain or systemic illness

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a thorough clinical examination by a healthcare professional followed by a skin biopsy where a small sample of the lesion is removed and examined microscopically. The biopsy confirms the presence of carcinoma in situ, indicating that the abnormal cells are confined to the epidermis and have not invaded deeper layers. Additional imaging may be used if there is suspicion of spread or involvement beyond the skin.

Treatment Protocols: Treatment strategies focus on removing or destroying the abnormal cells to prevent progression to invasive skin cancer. Common options include: - **Surgical excision:** Cutting out the lesion with a margin of healthy tissue - **Cryotherapy:** Freezing the abnormal cells with liquid nitrogen - **Topical treatments:** Application of medications like imiquimod or fluorouracil to promote lesion clearance - **Photodynamic therapy:** Using light-activated drugs to destroy affected cells - **Laser therapy:** Targeted laser destruction of abnormal tissue Follow-up monitoring is essential to ensure complete removal and to check for any signs of recurrence or progression.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D04.7 a billable ICD-10 code?
Yes, D04.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D04.7?
Clinical documentation must specify the nature of Carcinoma in situ of skin of lower limb, including hip and any associated comorbidities for accurate reporting.

Cite this Clinical Reference